文献速递哮喘

哮喘患者支气管上皮IgA分泌受损及IL-4/IL-13的作用

Bronchial Epithelial IgA Secretion Is Impaired in Asthma. Role of IL-4/IL-13.
PubMed 文献 · Am J Respir Crit Care Med · 2018-01-01

该研究探讨哮喘患者支气管上皮多聚免疫球蛋白受体(pIgR)的表达及其与2型炎症的关系。结果显示哮喘患者支气管上皮pIgR蛋白表达下调(P=0.0002 vs. 对照组),且IL-4/IL-13可通过自分泌TGF-β途径抑制pIgR表达和IgA转运。提示2型免疫激活通过TGF-β通路损害分泌型IgA介导的黏膜防御。

要点

  • 哮喘患者支气管上皮pIgR蛋白表达显著降低。
  • IL-4/IL-13通过自分泌TGF-β抑制pIgR和IgA转运。
  • 该缺陷在体外培养的哮喘上皮中未再现,提示微环境调控。

核心结论

  • 哮喘患者支气管上皮pIgR表达受损,可能影响分泌型IgA介导的前线防御。
  • IL-4/IL-13通过TGF-β通路部分介导pIgR下调。

研究设计与样本

  • 比较哮喘患者与对照者支气管活检组织及体外气液界面培养上皮的pIgR表达。
  • 检测2型生物标志物与pIgR的相关性,并体外验证IL-4/IL-13调控机制。

主要发现

  • 哮喘患者支气管上皮pIgR蛋白表达下调(P=0.0002 vs. 对照组)。
  • 体外培养的哮喘患者上皮未再现pIgR表达缺陷。
  • 外源性IL-13和IL-4可抑制pIgR表达及IgA转胞吞作用。
  • 自分泌TGF-β介导IL-4/IL-13对pIgR的抑制作用,部分涉及TGF-α/EGFR上调。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE: Asthma is associated with increased lung IgE production, but whether the secretory IgA system is affected in this disease remains unknown. OBJECTIVES: We explored mucosal IgA transport in human asthma and its potential regulation by T-helper cell type 2 inflammation. METHODS: Bronchial biopsies from asthma and control subjects were assayed for bronchial epithelial polymeric immunoglobulin receptor (pIgR) expression and correlated to T-helper cell type 2 biomarkers. Bronchial epithelium reconstituted in vitro from these subjects, on culture in air-liquid interface, was assayed for pIgR expression and regulation by IL-4/IL-13. MEASUREMENTS AND MAIN RESULTS: Downregulation of pIgR protein was observed in the bronchial epithelium from patients with asthma (P = 0.0002 vs. control subjects). This epithelial defect was not observed ex vivo in the cultured epithelium from patients with asthma. Exogenous IL-13 and IL-4 could inhibit pIgR expression and IgA transcytosis. Mechanistic experiments showed that autocrine transforming growth factor-β mediates the IL-4/IL-13 effect on the pIgR, with a partial contribution of upregulated transforming growth factor-α/epidermal growth factor receptor. CONCLUSIONS: This study shows impaired bronchial epithelial pIgR expression in asthma, presumably affecting secretory IgA-mediated frontline defense as a result of type 2 immune activation of the transforming growth factor pathway.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Ladjemi MZ, Gras D, Dupasquier S, et al. Bronchial Epithelial IgA Secretion Is Impaired in Asthma. Role of IL-4/IL-13. Am J Respir Crit Care Med. 2018. PMID: 29652177. doi:10.1164/rccm.201703-0561OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。